| 发明名称 |
PRODUCT COMPRISING AT LEAST A NO SYNTHASE INHIBITING SUBSTANCE ASSOCIATED WITH AT LEAST A PHOSPHOLIPASE A2 INHIBITING SUBSTANCE |
| 摘要 |
The invention concerns a product comprising at least a NO synthase inhibiting substance associated with at least a phospholipase A2 inhibiting substance, separately or combined, for simultaneous therapeutic use, separately or spread over time for treating pathologies in which nitrogen monoxide and/or phospholipases A2 are involved. The invention also concerns a pharmaceutical composition comprising, an active principle, at least a NO synthase inhibiting substance and at least a phospholipase A2 inhibiting substance, and optionally a pharmaceutically acceptable. |
| 申请公布号 |
PL202997(B1) |
申请公布日期 |
2009.08.31 |
| 申请号 |
PL20000355285 |
申请日期 |
2000.11.03 |
| 申请人 |
SOCIETE DE CONSEILS DE RECHERCHES ET D'APPLICATIONS SCIENTIFIQUES (S.C.R.A.S.) |
发明人 |
AUGUET MICHEL;CHABRIER DE LASSAUNIERE PIERRE-ETIENNE |
| 分类号 |
A61K45/00;A61K45/06;A61K31/155;A61K31/343;A61K31/36;A61K31/416;A61K31/427;A61K31/473;A61P1/00;A61P1/08;A61P1/10;A61P1/12;A61P3/00;A61P9/00;A61P9/10;A61P9/12;A61P11/00;A61P13/12;A61P17/00;A61P17/02;A61P17/06;A61P17/16;A61P19/00;A61P19/02;A61P19/04;A61P21/00;A61P25/00;A61P25/02;A61P25/28;A61P27/00;A61P29/00;A61P31/00;A61P31/12;A61P31/18;A61P33/00;A61P35/00;A61P37/00;A61P37/06;A61P41/00;A61P43/00 |
主分类号 |
A61K45/00 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
